tmRNA Inhibitors as Antibacterial Agents
The researchers have developed methods and compositions of matter relating to inhibitors of the tmRNA pathway. These potential therapeutics have antibacterial activity with broad species specificity, including B. anthracis and other pathogens of military and civilian interest. Identified compositions have been demonstrated to kill bacterial pathogens when added exogenously. -Steven Benkovic & Ken Keiler
We work together with the Office of Technology Management (OTM) and the Office for Industrial Partnerships (OIP), engaging in assisting inventors in capturing Intellectual Property (IP), and providing academic resources and support to entrepreneurs.